Find and Pitch Jounalists, Get Your Story Covered

Tags: Myelofibrosis inpatient to outpatient transitions medication reconciliation platelets platelet

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis - 23 days ago FDA Panel Endorses Imetelstat for MDS-Related Anemia - 11 months ago FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia - 11 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 12 months ago Ruxolitinib Combinations Reduce Spleen Volume in Myelofibrosis - about 1 year ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - about 1 year ago
2	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma - about 1 month ago Mezigdomide Combinations Show Promise in Multiple Myeloma - about 1 month ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 7 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - about 1 year ago Why Some Myeloma Patients Refuse Stem Cell Transplant - about 1 year ago High NfL Levels Predict Greater MS Disability Within 2 Years - about 1 year ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	ASH 2024 Recap: Movement in Multiple Myeloma, Cell Therapy, Sickle Cell Disease & More - about 2 months ago FDA Rejection Delays Regeneron From Competing With J&J, Pfizer in Multiple Myeloma - 5 months ago
4	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - about 2 months ago Arcellx to present positive data on multiple myeloma treatments - 3 months ago Scotland first in UK to approve new myeloma treatment - 5 months ago
5	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	Study paints clearer picture of disadvantaged leukemia patients’ struggle to get bone marrow transplants - about 2 months ago
6	Emily Cooke Live Science Health reporter. London, United Kingdom healthscience	Stone man disease: A rare condition that causes a person to grow a second skeleton - 2 months ago
7	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	FDA Investigating Blood Cancer Risk With Gene Therapy Skysona - 2 months ago
8	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Final Thoughts - 2 months ago
9	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - 3 months ago
10	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Extends Approval of Fibryga to Include Bleeding Patients With Acquired Fibrinogen Deficiency - 6 months ago FDA Grants Priority Review for Asciminib for Chronic Myeloid Leukemia - 6 months ago Luspatercept Reduces Transfusion Burden Compared With Epoetin Alfa - 8 months ago FDA Approves Idecabtagene Vicleucel for Multiple Myeloma After 2 or More Lines of Therapy - 10 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - about 1 year ago FDA Grants Breakthrough Therapy Designation to Novel Drug for Progressive Pulmonary Fibrosis - over 1 year ago

Journalists covering Myelofibrosis